Saskia M C Langemeijer

5PUBLICATIONS
29CO-AUTHORS
Respiratory diseasesMedical infection agents (incl. prions)Major global burdens of diseaseMedical virologyMedicinal and biomolecular chemistry not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Aleksandar Savic, Adele Taylor, Pierre Fenaux

|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromes.

Joanne Topping, Adele Taylor, Fatima Nadat

|Feb 22, 2023
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes.

Charlotte C M Schaap, Floor C J I Heubel-Moenen, Erfan Nur

|Nov 06, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.

Krzysztof Mądry, Karol Lis, Pierre Fenaux

|Dec 17, 2019
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).

Saskia Schols, Miles A Nunn, Ian Mackie

Pageof 1

Frequent Collaborators

3 joint publications

Argiris Symeonidis

3 joint publications

Alexandra Smith

2 joint publications

Pierre Fenaux

2 joint publications

Moshe Mittelman